Sort
82,697 grants matching “vaccine development”
Evolution of anti-filovirus B cell responses and mechanisms of protection
$742,509M. Javad Aman · Integrated Biotherapeutics, Inc. · R01 · FY2019 · AI
01 Inflammation, Immunology and Immunotherapeutics Program
$742,500Donald J Buchsbaum · University Of Alabama At Birmingham · P30 · FY2020 · CA
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
$742,500Barry P Sleckman · University Of Alabama At Birmingham · P30 · FY2020 · CA
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$742,473Weill Medical College Of Cornell Univ · P01 · FY2003 · AI
Malaria Immunology and Pathogenesis in Pregnant Women and Young Children
$742,469Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Exploiting glycan holes and sequence diversity of naturally occurring HIV envelope towards the design of vaccine immunogen panels for induction of neutralization breadth
$742,463Cynthia Ann Derdeyn · University Of Washington · R01 · FY2024 · AI
Understanding measles vaccine failure (and success) in Southern India
$742,443Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2021 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2021 · AI
Conjugate vaccines for prevention and treatment of cryptococcosis
$742,433Arturo Casadevall · Johns Hopkins University · R01 · FY2020 · AI
Immune Monitoring Core
$742,429Andrew S. Neish · Emory University · U54 · FY2020 · CA
Developing recombinant coronavirus vaccines for SARS
$742,409University Of Arkansas Med Scis Ltl Rock · U01 · FY2005 · AI
Polypeptide Microbicides Targeting CCR5
$742,323University Of Md Biotechnology Institute · P01 · FY2001 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$742,254Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Developing a Multi-epitope Pan-Coronavirus Vaccine
$742,241Lbachir Benmohamed · University Of California-Irvine · R01 · FY2023 · AI
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
$742,199Lanying Du · Georgia State University · R01 · FY2022 · AI
Establishment of Specific Free Rhesus and Pigtail Macques Colonies
$742,187Michael K Axthelm · Oregon Health & Science University · U24 · FY2014 · OD
Advancing a Lead Candidate Hantavirus Pulmonary Syndrome DNA Vaccine
$742,164Jay Williams Hooper · Geneva Foundation · R01 · FY2013 · AI
Dynamics of antigen specific B and Tfh responses during acute and chronic HCV
$742,154Arash Grakoui · Emory University · R01 · FY2021 · AI
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
$742,138Scott C Weaver · University Of Texas Med Br Galveston · R24 · FY2019 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$742,132Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Potent broadly neutralizing antibody development against the HIV-1 fusion peptide epitope
$742,110Brandon James Dekosky · Massachusetts General Hospital · R01 · FY2023 · AI
Mechanisms of compromised CD8 T cell responses to vaccination in malaria experienced hosts
$742,107John T. Harty · University Of Iowa · R01 · FY2025 · AI
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$742,058Jennifer K Hoffman · Duke University · R01 · FY2023 · AI
Origins and dynamics of HIV gp120 specific B cell memory in HIV negative high-risk individuals
$742,053James J Kobie · University Of Alabama At Birmingham · R01 · FY2025 · AI
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI